NCT00002249已完成1 期
A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
To determine the safety and pharmacokinetics of L-ofloxacin (RWJ 25213) in patients with HIV infection.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's SarcomaHIV PositiveAIDSKaposi's SarcomaNCT02029430ImmunityBio, Inc.15
撤回
4 期
Pharmacotherapy for HIV Infected Patients With Alcohol ProblemsHIV InfectionHeavy Alcoholic ConsumptionHIV InfectionsNCT00854230VA Connecticut Healthcare System
已完成
1 期
A Study of LXR015-1 in HIV-Infected PatientsHIV InfectionsNCT00002365LXR Biotechnology30
已完成
不适用
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With AnemiaCytopeniasHIV InfectionsNCT00002042Ortho Pharmaceuticals
进行中（未招募）
1 期
Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)HIVTuberculosisNCT05122767The Aurum Institute NPC92